Indoco Remedies Ltd
NSE:INDOCO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Edianyun Ltd
HKEX:2416
|
CN |
|
va Q tec AG
OTC:VAQTF
|
DE |
Indoco Remedies Ltd
Intangible Assets
Indoco Remedies Ltd
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Indoco Remedies Ltd
NSE:INDOCO
|
Intangible Assets
₹1.7B
|
CAGR 3-Years
23%
|
CAGR 5-Years
13%
|
CAGR 10-Years
8%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Intangible Assets
₹100.9B
|
CAGR 3-Years
47%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Intangible Assets
₹19.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
26%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Intangible Assets
₹136.8B
|
CAGR 3-Years
32%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Lupin Ltd
NSE:LUPIN
|
Intangible Assets
₹25.2B
|
CAGR 3-Years
24%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Intangible Assets
₹40.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
Indoco Remedies Ltd
Glance View
Indoco Remedies Ltd. engages in manufacturing and marketing of Formulations (Finished Dosage Forms) and active pharmaceutical ingredients. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2005-01-07. The firm is an integrated, research-oriented pharma company engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The firm's geographical segments include India and Outside India. The firm has nine domestic marketing divisions with a brand portfolio in various therapeutic segments, including Gastrointestinal, Respiratory, Anti-Infective, Stomatologicals, Ophthalmic, Nutritionals, Cardiovascular, Anti-Diabetics, Pain Management and Gyneacology. The Company’s brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital, Sensoform, Sensodent-KF, Cal-Aid, Cloben-G, Glychek, Kidodent, Carmicide, Rexidin, MCBM and Methycal.
See Also
What is Indoco Remedies Ltd's Intangible Assets?
Intangible Assets
1.7B
INR
Based on the financial report for Mar 31, 2025, Indoco Remedies Ltd's Intangible Assets amounts to 1.7B INR.
What is Indoco Remedies Ltd's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
8%
Over the last year, the Intangible Assets growth was 3%. The average annual Intangible Assets growth rates for Indoco Remedies Ltd have been 23% over the past three years , 13% over the past five years , and 8% over the past ten years .
